PLG is very excited to announce the re-start of our monthly newsletter, to keep everyone up to date with our activities and news.
Please see link:
https://productlifegroup.com/blog/february-newsletter/
Cambridge, UK, 23rd February 2021: Chesterford Research Park is delighted to confirm the expansion of Camena Bioscience within the Science Village Building at the Park. The developer of an industry-leading DNA synthesis technology has renewed its existing lease for a further five years and in tandem taken an additional 1,993 sq ft adjoining suite on the same terms.Founded in 2016, Camena Bioscience has been based at Chesterford Research Park since its incorporation. The company’s multi-enzymatic technology, called gSynth™, has dramatically improved the accuracy of DNA synthesis…
Ahead of the Chancellor’s Budget on 3rd March 2021, Cambridge Tax Partner Hannah Simoes and Deloitte experts give their key predictions for the event. The UK’s regions continue as an expected area of focus in this Budget.
Economic outlook
Ian Stewart, chief economist, said:
“The focus of this Budget should be on growth. The heavy lifting needed to rebuild the public finances will need to wait until the recovery is well entrenched. This Budget is likely to outline a road map for the winding down of pandemic support schemes along with more limited and selective support for at risk sectors.…
Stevenage Bioscience Catalyst (SBC) has launched a free accelerator programme to give data-focussed biotech start-ups the skills they need to get potential new drugs and therapiesto market more quickly.The programme will run from May and is aimed at supporting start-up companies working to discover new drugs. Those selected will take part in an 18-week programme during which they will have the opportunity to network and learn from experts in the pharmaceutical and biotech industries. Start-ups will be able to build their expertise in structuring deals, accessing data,…
A first of its kind virtual platform - ‘UK Healthcare Pavilion’ - that showcases the very best of UK healthcare and life sciences, has been launched.
The site provides news, insights, and interviews from a variety of key opinion leaders and policy makers, offering their views on topical subjects in the sector and showcasing the strengths the UK has to offer.
The platform will support UK companies to increase export opportunities, as alongside this is a searchable directory of UK companies providing overseas buyers with a simple and intuitive way to identify and engage with UK industry…
A team of Discovery Park scientists researching human neurological and psychiatric health conditions is expanding research opportunities for its Kent-based team in mainland Europe, by opening an additional laboratory in Poland.
The Transpharmation team only announced the move of its headquarters and main laboratory to Discovery Park itself in November 2020, and started working from its laboratories there this month (February 2021). The additional Poland expansion means newly-recruited scientists, students and research assistants at Discovery Park will be able to forge new relationships with…
The 2020 annual report for the Centre for Behaviour Change (CBC) is now available.2020 presented a unique set of challenges to individuals, communities and organisations alike. The science and practice of behaviour change has been at the forefront of the international response to, and recovery from, COVID-19. The CBC team, both its core staff and associates, have been at the heart of many national and international initiatives to apply behaviour change science to controlling infection rates and minimising harms associated with the pandemic. In addition, it has been able to continue to develop…
AMSBIO has introduced a collection of mutated SARS-CoV-2 spike proteins and recombinant antigens for the new virus variants - B.1.1.7 and B.1.351. These reagents can be used by researchers to evaluate the efficacy of the antibodies and identify targets for development of improved therapeutic drugs and vaccines.Emerging in the latter part of 2020, multiple new SARS-CoV-2 variants are now circulating globally. Most notably in the UK, a new variant strain of SARS-CoV-2 (known as B.1.1.7) emerged with an unusually large number of mutations. This variant has since been detected in numerous…
Business clusters in the Oxford-Cambridge Arc region have strongly welcomed the government’s announcement today that it will identify the needs to propel the Arc’s innovation-led economy.
By developing its Spatial Framework Plan, government will bring together the key enablers of sustainable growth to discuss innovation, science and deep technology skills, the commercial property spaces and digital infrastructure that business needs, and the sustainable transport, environment and housing that employees want.
The Arc region spans the five counties of Oxfordshire, Buckinghamshire,…
CAMBRIDGE, MASS., and LONDON – February 16, 2021 – Centessa Pharmaceuticals (“Centessa”) launched today as a novel asset-centric pharmaceutical company designed and built to advance a portfolio of highly validated programs. Centessa’s asset-centric R&D model applied at scale has assembled best-in-class or first-in-class assets, each of which is led by specialized teams committed to accelerate development and reshape the traditional drug development process. The company was founded by Medicxi and raised $250 million in an oversubscribed Series A financing led by General Atlantic and co-led…